RESOLUTION FOR DONATION OF LONG ACTING INJECTABLES (LAIS).PDF
Extracted text (via pymupdf)
17792 characters
RESOLUTION:
Outpatient Sample Program with Alkermes, Inc, Otsuka America Pharmaceutical, Inc, and Janssen Pharmaceuticals, Inc.
Long-Acting Injectable Antipsychotic Medications
WHEREAS, an average of 213 Long-Acting Injectable ("LAI") antipsychotic medications are administered by Maricopa
County Correctional Health Services (CHS) to patients per month, comprising 55% of the annual pharmacy budget for CHS,
with an average daily jail population of 6,774;
WHEREAS, recent medical literature indicates that adherence to antipsychotic medication may lead to a decrease in criminal
recidivism, and where patients are carefully selected, for LAI treatment, in combination with discharge planning and "warm
handoffs," there is the potential of decreasing the recidivism of this vulnerable patient population;
WHEREAS, partnering with pharmaceutical companies to receive LAI medications free of charge, Maricopa County CHS
will be able to continue these treatments on stable patients and initiate therapy on candidates who may benefit the most;
NOW THEREFORE:
BE IT RESOLVED, The Board of Supervisors will adopt this Resolution and authorize Maricopa County, through its
Department of CHS, to complete a non-financial Certification and Request form for free samples of the following injectable
medications, with the detailed breakdown shown on the following pages:
•
From Alkermes, Inc.
o
Aristada® in 441 mg, 662 mg, 882 mg, and 1064 mg doses
o
Aristada® Initio in 675 mg doses
o
Vivitrol® in 380 mg doses
•
From Otsuka America Pharmaceutical, Inc
o
Abilify Maintena® in 400 mg doses
o
Abilify Asimtufii® in 720 mg 960 mg doses
•
From Janssen Pharmaceuticals, Inc.
o
Invega Sustenna® in 156 mg and 234 mg doses
Dated this ____19_____ day of ________July_________________, 2024.
For and Behalf of Maricopa County
By___________________________
Chairman, Board of Supervisors
___________________________
Date
Attest:
___________________________
Clerk of the Board
___________________________
Date
Approved as to form:
___________________________
Deputy County Attorney
____________________________
Date
Docusign Envelope ID: E60EBBE6-4343-4BD9-B379-4A2FC0DD295E
7/22/2024
Medication
Quantity
Cost per
Dosage
Total Value
Donor
Abilify Maintena 400 Mg
484
$2,525.62
$1,222,400.08
Otsuka
Abilify Asimtufii 720Mg
0
$3,946.28
$0.00
Otsuka
Abilify Asimtufii 960Mg
58
$5,261.71
$305,179.18
Otsuka
Aristada 1064 Mg
17
$3,395.64
$57,725.88
Alkermes
Aristada 441 Mg
35
$1,407.40
$49,259.00
Alkermes
Aristada 662 Mg
36
$2,112.70
$76,057.20
Alkermes
Aristada 882 Mg
110
$2,814.80
$309,628.00
Alkermes
Aristada Initio 675 Mg
33
$2,154.20
$71,088.60
Alkermes
Vivitrol 380 Mg
155
$1,446.65
$224,230.75
Alkermes
Invega Sustenna 156 Mg
347
$2,158.51
$749,002.97
Janssen
Invega Sustenna 234 Mg
995
$3,237.69
$3,221,501.55
Janssen
Totals
2270
$6,286,073.21
Docusign Envelope ID: E60EBBE6-4343-4BD9-B379-4A2FC0DD295E
LAI Year End Report
FY 2024
Month:
FY 2024
Donation Date
Donor
Description of Item(s)
Restricted
Non
Restricted
No. of
items
Value (Amount)
7/26/2023
Otsuka
Abilify Maintena 400 mg
X
20
$50,512.40
7/31/2023
Otsuka
Abilify Maintena 400 mg
X
5
$12,628.10
7/6/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
7/11/2023
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
7/13/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
7/19/2023
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
7/6/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
7/11/2023
Janssen
Invega Sustena 234 mg
X
20
$64,753.80
7/12/2023
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
7/13/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
7/19/2023
Janssen
Invega Sustena 234 mg
X
28
$90,655.32
7/20/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
7/25/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
7/26/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
7/27/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
7/28/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
7/28/2023
Alkermes Aristada 882
X
10
$28,148.00
8/4/2023
Otsuka
Abilify Maintena 400 mg
X
20
$50,512.40
8/8/2023
Otsuka
Abilify Maintena 400 mg
X
5
$12,628.10
8/24/2023
Otsuka
Abilify Maintena 400 mg
X
5
$12,628.10
8/1/2023
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
8/11/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
8/24/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
8/25/2023
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
8/1/2023
Janssen
Invega Sustena 234 mg
X
24
$77,704.56
8/8/2023
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
8/11/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
8/15/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
8/17/2023
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
8/23/2023
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
8/24/2023
Janssen
Invega Sustena 234 mg
X
20
$64,753.80
8/25/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
8/29/2023
Alkermes Aristada 441
X
4
$5,629.60
8/29/2023
Alkermes Aristada 882
X
15
$42,222.00
8/29/2023
Alkermes Aristada 1064
X
3
$10,186.92
9/25/2023
Otsuka
Abilify Maintena 400 mg
X
30
$75,768.60
9/29/2023
Otsuka
Abilify Maintena 400 mg
X
10
$25,256.20
9/1/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
9/6/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
9/12/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
9/19/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
9/26/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
Printed: 7/19/2024
FY 2024 LAI Year End Report.xlsx
Docusign Envelope ID: E60EBBE6-4343-4BD9-B379-4A2FC0DD295E
LAI Year End Report
FY 2021
Month:
FY 2024
Donation Date
Donor
Description of Item(s)
Restricted
Non
Restricted
No. of
items
Value (Amount)
9/29/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
9/1/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
9/6/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
9/7/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
9/9/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
9/12/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
9/14/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
9/19/2023
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
9/22/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
9/26/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
9/27/2023
Janssen
Invega Sustena 234 mg
X
3
$9,713.07
9/29/2023
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
10/2/2023
Otsuka
Abilify Maintena 400 mg
X
40
$101,024.80
10/23/2023
Otsuka
Abilify Maintena 400 mg
X
70
$176,793.40
10/3/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
10/4/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
10/5/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
10/18/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
10/16/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
10/25/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
10/26/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
10/3/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
10/3/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
10/4/2023
Janssen
Invega Sustena 234 mg
X
24
$77,704.56
10/5/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
10/6/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
10/18/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
10/19/2023
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
10/25/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
10/25/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
10/25/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
10/26/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
10/31/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
10/13/2023
Alkermes Aristada 441
X
15
$21,111.00
10/13/2023
Alkermes Aristada 882
X
10
$28,148.00
10/13/2023
Alkermes Aristada 1064
X
3
$10,186.92
11/6/2023
Otsuka
Abilify Maintena 400 mg
X
10
$25,256.20
11/21/2023
Otsuka
Abilify Maintena 400 mg
X
10
$25,256.20
11/1/2023
Otsuka
Abilify Asimtufii 960 mg
X
14
$73,663.94
11/6/2023
Otsuka
Abilify Asimtufii 960 mg
X
2
$10,523.42
11/21/2023
Otsuka
Abilify Asimtufii 960 mg
X
2
$10,523.42
11/2/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
Printed: 7/19/2024
FY 2024 LAI Year End Report.xlsx
Docusign Envelope ID: E60EBBE6-4343-4BD9-B379-4A2FC0DD295E
LAI Year End Report
FY 2021
Month:
FY 2024
Donation Date
Donor
Description of Item(s)
Restricted
Non
Restricted
No. of
items
Value (Amount)
11/9/2023
Janssen
Invega Sustena 156 mg
X
12
$25,902.12
11/13/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
11/17/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
11/29/2023
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
11/2/2023
Janssen
Invega Sustena 234 mg
X
15
$48,565.35
11/8/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
11/8/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
11/9/2023
Janssen
Invega Sustena 234 mg
X
20
$64,753.80
11/13/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
11/16/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
11/17/2023
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
11/29/2023
Janssen
Invega Sustena 234 mg
X
16
$51,803.04
11/28/2023
Alkermes Aristada 675
X
15
$32,313.00
11/28/2023
Alkermes Aristada 662
X
6
$12,676.20
11/28/2023
Alkermes Aristada 882
X
6
$16,888.80
11/28/2023
Alkermes Aristada 1064
X
2
$6,791.28
12/11/2023
Otsuka
Abilify Maintena 400 mg
X
10
$25,256.20
12/12/2023
Otsuka
Abilify Maintena 400 mg
X
10
$25,256.20
12/13/2023
Otsuka
Abilify Maintena 400 mg
X
15
$37,884.30
12/15/2023
Otsuka
Abilify Maintena 400 mg
X
10
$25,256.20
12/20/2023
Otsuka
Abilify Maintena 400 mg
X
10
$25,256.20
12/27/2023
Otsuka
Abilify Maintena 400 mg
X
5
$12,628.10
12/11/2023
Otsuka
Abilify Maintena 960 mg
X
5
$26,308.55
12/13/2023
Otsuka
Abilify Maintena 960 mg
X
2
$10,523.42
12/15/2023
Otsuka
Abilify Maintena 960 mg
X
2
$10,523.42
12/20/2023
Otsuka
Abilify Maintena 960 mg
X
2
$10,523.42
12/21/2023
Otsuka
Abilify Maintena 960 mg
X
1
$5,261.71
12/4/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
12/6/2023
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
12/12/2023
Janssen
Invega Sustena 156 mg
X
2
$4,317.02
12/19/2023
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
12/21/2023
Janssen
Invega Sustena 156 mg
X
18
$38,853.18
12/28/2023
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
12/4/2023
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
12/6/2023
Janssen
Invega Sustena 234 mg
X
6
$19,426.14
12/12/2023
Janssen
Invega Sustena 234 mg
X
22
$71,229.18
12/21/2023
Janssen
Invega Sustena 234 mg
X
6
$19,426.14
1/24/2024
Otsuka
Abilify Maintena 400 mg
X
45
$113,652.90
1/26/2024
Otsuka
Abilify Maintena 400 mg
X
15
$37,884.30
1/24/2024
Otsuka
Abilify Maintena 960 mg
X
10
$52,617.10
1/26/2024
Otsuka
Abilify Maintena 960 mg
X
2
$10,523.42
1/3/2024
Janssen
Invega Sustena 156 mg
X
28
$60,438.28
Printed: 7/19/2024
FY 2024 LAI Year End Report.xlsx
Docusign Envelope ID: E60EBBE6-4343-4BD9-B379-4A2FC0DD295E
LAI Year End Report
FY 2021
Month:
FY 2024
Donation Date
Donor
Description of Item(s)
Restricted
Non
Restricted
No. of
items
Value (Amount)
1/4/2024
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
1/10/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
1/18/2024
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
1/22/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
1/26/2024
Janssen
Invega Sustena 156 mg
X
1
$2,158.51
1/31/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
1/3/2024
Janssen
Invega Sustena 234 mg
X
13
$42,089.97
1/4/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
1/10/2024
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
1/11/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
1/18/2024
Janssen
Invega Sustena 234 mg
X
26
$84,179.94
1/18/2024
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
1/22/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
1/24/2024
Janssen
Invega Sustena 234 mg
X
14
$45,327.66
1/26/2024
Janssen
Invega Sustena 234 mg
X
6
$19,426.14
1/31/2024
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
1/31/2024
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
1/9/2024
Alkermes Aristada 675
X
4
$8,616.80
1/9/2024
Alkermes Aristada 662
X
10
$21,127.00
1/9/2024
Alkermes Aristada 882
X
15
$42,222.00
1/24/2024
Otsuka
Abilify Maintena 960 mg
X
10
$52,617.10
1/26/2024
Otsuka
Abilify Maintena 960 mg
X
2
$10,523.42
2/12/2024
Otsuka
Abilify Maintena 400 mg
X
50
$126,281.00
2/12/2024
Otsuka
Abilify Maintena 960 mg
X
2
$10,523.42
2/13/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
2/27/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
2/2/2024
Janssen
Invega Sustena 234 mg
X
18
$58,278.42
2/5/2024
Janssen
Invega Sustena 234 mg
X
2
$6,475.38
2/6/2024
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
2/8/2024
Janssen
Invega Sustena 234 mg
X
2
$6,475.38
2/13/2024
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
2/16/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
2/27/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
2/13/2024
Alkermes Aristada 441
X
6
$8,444.40
2/13/2024
Alkermes Aristada 675
X
5
$10,771.00
2/13/2024
Alkermes Aristada 882
X
11
$30,962.80
2/12/2024
Otsuka
Abilify Asimtufii 960 mg
X
2
$10,523.42
3/28/2024
Otsuka
Abilify Maintena 400 mg
X
5
$12,628.10
3/6/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
3/7/2024
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
3/14/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
3/21/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
Printed: 7/19/2024
FY 2024 LAI Year End Report.xlsx
Docusign Envelope ID: E60EBBE6-4343-4BD9-B379-4A2FC0DD295E
LAI Year End Report
FY 2021
Month:
FY 2024
Donation Date
Donor
Description of Item(s)
Restricted
Non
Restricted
No. of
items
Value (Amount)
3/28/2024
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
3/1/2024
Janssen
Invega Sustena 234 mg
X
2
$6,475.38
3/4/2024
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
3/6/2024
Janssen
Invega Sustena 234 mg
X
24
$77,704.56
3/7/2024
Janssen
Invega Sustena 234 mg
X
16
$51,803.04
3/8/2024
Janssen
Invega Sustena 234 mg
X
6
$19,426.14
3/14/2024
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
3/20/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
3/21/2024
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
3/22/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
3/28/2024
Janssen
Invega Sustena 234 mg
X
14
$45,327.66
3/6/2024
Alkermes Aristada 441
X
3
$4,222.20
3/29/2024
Alkermes Aristada 441
X
7
$9,851.80
3/29/2024
Alkermes Aristada 675
X
6
$12,925.20
3/6/2024
Alkermes Aristada 662
X
8
$16,901.60
3/29/2024
Alkermes Aristada 662
X
6
$12,676.20
3/6/2024
Alkermes Aristada 882
X
15
$42,222.00
3/29/2024
Alkermes Aristada 882
X
8
$22,518.40
3/29/2024
Alkermes Aristada 1064
X
3
$10,186.92
4/2/2024
Otsuka
Abilify Maintena 400 mg
X
49
$123,755.38
4/2/2024
Janssen
Invega Sustena 156 mg
X
2
$4,317.02
4/9/2024
Janssen
Invega Sustena 156 mg
X
14
$30,219.14
4/23/2024
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
4/24/2024
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
4/30/2024
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
4/26/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
4/25/2024
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
4/24/2024
Janssen
Invega Sustena 234 mg
X
20
$64,753.80
4/23/2024
Janssen
Invega Sustena 234 mg
X
10
$32,376.90
4/19/2024
Janssen
Invega Sustena 234 mg
X
10
$32,376.90
4/17/2024
Janssen
Invega Sustena 234 mg
X
2
$6,475.38
4/9/2024
Janssen
Invega Sustena 234 mg
X
22
$71,229.18
4/5/2024
Janssen
Invega Sustena 234 mg
X
2
$6,475.38
4/2/2024
Janssen
Invega Sustena 234 mg
X
2
$6,475.38
4/2/2024
Janssen
Invega Sustena 234 mg
X
12
$38,852.28
5/7/2024
Alkermes Aristada 675
X
3
$6,462.60
5/7/2024
Alkermes Aristada 662
X
6
$12,676.20
5/7/2024
Alkermes Aristada 882
X
20
$56,296.00
5/7/2024
Alkermes Aristada 1064
X
6
$20,373.84
5/2/2024
Janssen
Invega Sustena 156 mg
X
6
$12,951.06
5/7/2024
Janssen
Invega Sustena 156 mg
X
8
$17,268.08
5/25/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
Printed: 7/19/2024
FY 2024 LAI Year End Report.xlsx
Docusign Envelope ID: E60EBBE6-4343-4BD9-B379-4A2FC0DD295E
LAI Year End Report
FY 2021
Month:
FY 2024
Donation Date
Donor
Description of Item(s)
Restricted
Non
Restricted
No. of
items
Value (Amount)
5/1/2024
Janssen
Invega Sustena 234 mg
X
6
$19,426.14
5/2/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
5/7/2024
Janssen
Invega Sustena 234 mg
X
20
$64,753.80
5/9/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
5/15/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
5/16/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
5/25/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
5/31/2024
Janssen
Invega Sustena 234 mg
X
16
$51,803.04
6/5/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
6/6/2024
Janssen
Invega Sustena 156 mg
X
12
$25,902.12
6/18/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
6/26/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
6/27/2024
Janssen
Invega Sustena 156 mg
X
4
$8,634.04
6/5/2024
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
6/6/2024
Janssen
Invega Sustena 234 mg
X
16
$51,803.04
6/13/2024
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
6/15/2024
Janssen
Invega Sustena 234 mg
X
10
$32,376.90
6/18/2024
Janssen
Invega Sustena 234 mg
X
14
$45,327.66
6/25/2024
Janssen
Invega Sustena 234 mg
X
8
$25,901.52
6/26/2024
Janssen
Invega Sustena 234 mg
X
4
$12,950.76
6/27/2024
Janssen
Invega Sustena 234 mg
X
14
$45,327.66
6/11/2024
Otsuka
Abilify Maintena 400 mg
X
10
$25,256.20
6/13/2024
Otsuka
Abilify Maintena 400 mg
X
5
$12,628.10
6/26/2024
Otsuka
Abilify Maintena 400 mg
X
20
$50,512.40
Printed: 7/19/2024
FY 2024 LAI Year End Report.xlsx
Docusign Envelope ID: E60EBBE6-4343-4BD9-B379-4A2FC0DD295E
Month:
FY 2024
Donation Date
Donor
Description of Item(s)
Restricted
Non
Restricted
No. of items
Value (Amount)
7/6/2023
Vivitrol 380MG
X
15
$21,699.75
7/28/2023
Vivitrol 380MG
X
15
$21,699.75
9/13/2023
Vivitrol 380MG
X
15
$21,699.75
10/5/2023
Vivitrol 380MG
X
15
$21,699.75
11/28/2023
Vivitrol 380MG
X
15
$21,699.75
1/9/2024
Vivitrol 380MG
X
20
$28,933.00
2/20/2024
Vivitrol 380MG
X
20
$28,933.00
4/5/2024
Vivitrol 380MG
X
20
$28,933.00
5/29/2024
Vivitrol 380MG
X
20
$28,933.00
Docusign Envelope ID: E60EBBE6-4343-4BD9-B379-4A2FC0DD295E